Andrographolide, a diterpene lactone from Andrographis paniculata and its therapeutic promises in cancer
2018
Abstract The
diterpenelactone
andrographolide, isolated from
Andrographis paniculata, has been proven to possess several important protective biological activities, including antioxidant, anti-inflammatory, immunomodulatory,
antiseptic, antimicrobial, cytotoxic, hypolipidemic, cardioprotective,
hepatoprotective, and neuroprotective effects. In addition, it has been reported to play a therapeutic role in the treatment of major human diseases, such as Parkinson's disease, rheumatoid arthritis, and colitis. This systematic review aims to highlight
andrographolideas a promising agent in cancer treatment. To this purpose, a number of databases were used to search for the cytotoxic/anticancer effects of
andrographolidein pre-clinical and clinical studies. Among 1703 identified literature articles, 139 were included in this review; 109 were investigated as non-clinical, whereas 24, 3, and 3 were pre-clinical, clinical, and non-pre-clinical trials, respectively. Among the model systems, cultured cell lines appeared as the most frequently (79.14%) used, followed by in vivo models using rodents, among others. Furthermore,
andrographolidewas found to exert cytotoxic/anticancer effects on almost all types of cell lines with the underlying mechanisms involving oxidative stress, cell cycle arrest, anti-inflammatory and immune system mediated effects, apoptosis, necrosis, autophagy, inhibition of cell adhesion, proliferation, migration, invasion, anti-angiogenic activity, and other miscellaneous actions. After careful consideration of the relevant evidence, we suggest that
andrographolidecan be one of the potential agents in the treatment of cancer in the near future.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
155
References
57
Citations
NaN
KQI